相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Covid-19-Navigating the Uncharted
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Alfred H. J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Matt Arentz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
Angela Ceribelli et al.
JOURNAL OF AUTOIMMUNITY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Philip C. Robinson et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis (vol 58, pg e3, 2019)
Christopher R. Holroyd et al.
RHEUMATOLOGY (2019)
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative
Andrew D. Dick et al.
OPHTHALMOLOGY (2018)
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
Kevin L. Winthrop et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis
Yasir Jamal Sepah et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
分享论文
